|
|
Article: Acquisition to advance treatment of viral diseases and neurological disorders.
- Article from:
- Drug Week
- Article date:
- January 16, 2004
CopyrightCOPYRIGHT 2004 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
2004 JAN 16 - (NewsRx.com & NewsRx.net) -- Nutra Pharma Corp. (NPHC) has signed a definitive agreement, subject to the approval of Receptopharm's board of directors, to acquire 50% of the capital stock of Receptopharm, Inc., for a cash infusion of $2 million, to further develop and advance Nutra Pharma's licenses to patents acquired from BioTherapeutics Inc. for the treatment of certain viral diseases and neurological disorders
"The acquisition of 50% of Receptopharm, Inc. will allow Nutra Pharma to capitalize its recent intellectual property acquisition, which includes effective drug delivery mechanisms and a host of drug candidates to build upon," said Rik ...